If you’ve never heard of Bill James, don’t feel bad. Until recently, his name was only... Read More

If you’ve never heard of Bill James, don’t feel bad. Until recently, his name was only reverently whispered among circles of “statheads” — a small but growing community... Read More

The market is new all-time highs, unemployment is near its record low, the U.S. economy is in its... Read More

The market is new all-time highs, unemployment is near its record low, the U.S. economy is in its longest-ever expansion cycle, and the Federal Reserve is discussing a rate cut. Welcome to the new... Read More

There’s a handful of well-known names that have left their imprint on the investing world,... Read More

There’s a handful of well-known names that have left their imprint on the investing world, whether it was with unprecedented streaks of market-beating returns or famous bets against major... Read More

It’s hard to predict whether a stock will do well. Many investors simply follow the trend:... Read More

It’s hard to predict whether a stock will do well. Many investors simply follow the trend: buying high in order to sell even higher. This momentum strategy is a valid one. Like a freight train,... Read More

Earlier this month, my colleague Brad Briggs gave a few details on how our system works over at... Read More

Earlier this month, my colleague Brad Briggs gave a few details on how our system works over at Maximum Profit, my premium newsletter advisory service. If you read that article, then you know that... Read More

Not every company is created the same, and not every cybersecurity system works to protect against... Read More

Not every company is created the same, and not every cybersecurity system works to protect against the same set of threats.  For example, some of you may remember Mimecast (Nasdaq: MIME) —... Read More

Biotech is hot. A number of sizeable deals — and expectations of more — keep the sector... Read More

Biotech is hot. A number of sizeable deals — and expectations of more — keep the sector in the headlines and in the minds of investors.  Just a few days ago, on June 17, Pfizer... Read More

There are about 13,400 publicly-traded securities on U.S. exchanges. Of those, only about 2,100 of... Read More

There are about 13,400 publicly-traded securities on U.S. exchanges. Of those, only about 2,100 of those stocks pay a dividend. Now, any knucklehead with a computer can generate a list of the... Read More

Some of you know that I used to co-write our Maximum Profit premium newsletter with my colleague... Read More

Some of you know that I used to co-write our Maximum Profit premium newsletter with my colleague Jimmy Butts.  And while Jimmy is still at the helm, I’ve since moved on to greener... Read More

Most of the stocks we consider for our portfolio over at Fast-Track Millionaire are so-called... Read More

Most of the stocks we consider for our portfolio over at Fast-Track Millionaire are so-called “growth” stocks. This should not surprise anybody: we look for the leaders of tomorrow, for... Read More